Our Research Priorities
Drive Strategic Investments
July 20, 2017
MJFF is partnering to send LRRK2 protein to the International Space Station to grow larger LRRK2 crystals, which can help develop therapies. Michael J. Fox shares a special message on this project.
July 11, 2017
In the latest in our "Getting to a Cure: Science behind the Search" series, we cover the proposed connection between sticky protein alpha-synuclein and the immune system.
UPCOMING FUNDING PROGRAM DEADLINES
Deadline: Pre-Proposals Due: October 19, 2016 - 5pm US ET
Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program supports Parkinson's disease therapeutic development along the pre-clinical and clinical path (both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches).
Deadline: We are no longer accepting pre-proposals at this time.
Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.